BioPharma Credit PLC declare an interim dividend in respect of the financial period ended 30 September 2023 of $0.0375 per ordinary share, payable on 5 January 2024 to ordinary shareholders on the register as at 8 December 2023. The ex-dividend date will be 7 December 2023. The $0.0375 dividend comprises an ordinary dividend of $0.0175 and a special dividend of $0.0200The Company is currently paying and continues to target a 7 cent annual dividend per ordinary share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.88 USD | +0.46% | 0.00% | +4.76% |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
02/05 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+4.76% | 107.17Cr | |
+5.57% | 1.29TCr | |
+10.99% | 958.65Cr | |
+0.58% | 563.77Cr | |
+5.59% | 538.38Cr | |
+6.22% | 521.38Cr | |
+20.79% | 468.85Cr | |
+19.35% | 452.95Cr | |
+2.49% | 407.19Cr | |
+7.28% | 387.04Cr |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- Biopharma Credit plc Declares Special Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024